Provided by Tiger Trade Technology Pte. Ltd.

Nuvation Bio, Inc.

6.07
+0.29005.02%
Post-market: 6.170.1000+1.65%19:30 EDT
Volume:5.74M
Turnover:34.88M
Market Cap:2.13B
PE:-13.84
High:6.16
Open:5.96
Low:5.92
Close:5.78
52wk High:9.75
52wk Low:2.99
Shares:351.12M
Float Shares:264.00M
Volume Ratio:0.89
T/O Rate:2.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4387
EPS(LYR):-0.6000
ROE:-47.81%
ROA:-12.36%
PB:8.40
PE(LYR):-10.12

Loading ...

Nuvation Bio - Proceeds to Fund Capped Calls, Repay Senior Loan, and General Corporate Purposes

THOMSON REUTERS
·
Jun 25

Nuvation Bio CFO Philippe Sauvage Disposes of 47,668 Common Shares Worth $286,650.16

Reuters
·
Jun 25

Nuvation Bio posts corporate deck spotlighting IBTROZI launch, oncology pipeline programs

Reuters
·
Jun 17

Nuvation Bio director Robert Mashal reports purchase of 25,000 shares for $118,250

Reuters
·
Jun 12

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Teva Pharmaceutical (TEVA) and Nuvation Bio (NUVB)

TIPRANKS
·
Jun 10

Will TRUST-II Quality-of-Life Data and Global Milestones Change Nuvation Bio's (NUVB) Narrative?

Simply Wall St.
·
Jun 07

Did New IBTROZI Quality‑of‑Life Data Just Shift Nuvation Bio’s (NUVB) Investment Narrative?

Simply Wall St.
·
May 29

Nuvation Bio held annual shareholder meeting

Reuters
·
May 28

Nuvation Bio to present at Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 28

Nuvation Bio’s Ibtrozi shows improved quality of life in NSCLC trial

TIPRANKS
·
May 27

Nuvation Bio to present TRUST-II quality-of-life data for IBTROZI in ROS1+ lung cancer at ASCO 2026

Reuters
·
May 27

H.C. Wainwright Reaffirms Their Buy Rating on Nuvation Bio (NUVB)

TIPRANKS
·
May 27

Analysts Are Bullish on Top Healthcare Stocks: Nuvation Bio (NUVB), Universal Health (UHS)

TIPRANKS
·
May 26

How Does Nuvation Bio’s (NUVB) IBTROZI Update Reframe Its Long-Term Oncology Investment Narrative?

Simply Wall St.
·
May 20

Nuvation Bio collaborating with Thermo Fisher to manufacture Ibtrozi in NSCLC

TIPRANKS
·
May 14

Nuvation Bio partners with Thermo Fisher for US manufacturing of IBTROZI

Reuters
·
May 14

Nuvation Bio to Collaborate With Thermo Fisher Scientific for U.S.-Based Manufacturing of Ibtrozi® for Ros1-Positive Non-Small Cell Lung Cancer

THOMSON REUTERS
·
May 14

Nuvation Bio says FDA accepts IBTROZI label update filing for ROS1+ NSCLC

Reuters
·
May 06

Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for Ibtrozi® (Taletrectinib) With Updated Duration of Response in Advanced Ros1-Positive Non-Small Cell Lung Cancer

THOMSON REUTERS
·
May 06

Nuvation Bio Inc - FDA Accepts Supplemental Nda for Ibtrozi in Advanced Ros1+ Nsclc; Target Action Date Jan 4, 2027

THOMSON REUTERS
·
May 06